CM355
CM355 (ICP-B02) is a CD20/CD3 bispecific IgG4 antibody. CM355 exhibits asymmetric affinity binding to CD20 and CD3. CM355 does not bind to Fcγ receptors (FcγR), which is designed to reduce the risk of cytokine release. CM355 can be used for research on B-cell non-Hodgkin lymphoma.
商品は「研究用試薬」です。人や動物の医療用・臨床診断用・食品用の製品ではありません。
研究用途以外に使用した場合、当社は一切の責任を負いかねます。
-
保管条件:
Please store the product under the recommended conditions in the Certificate of Analysis.
生物活性
製品説明
Species Reactivity
Human
体外実験
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
Target
CD3 & CD20
Conjugated
Unconjugated
アプリケーション
ELISA, FACS, Functional assay
化学情報
-
SMILES
[CM355]
-
別名
ICP-B02
-
保管条件
Please store the product under the recommended conditions in the Certificate of Analysis.
純度とドキュメンテーション
参考文献
Calculators
濃度 (開始) × 体積 (開始) = 濃度 (終了) × 体積 (終了)